OBJECTIVE: To explore associated clinical factors in children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS). STUDY DESIGN: Children with tics, obsessive-compulsive disorder, or both (n=109) were examined with personal and family history, diagnostic interview, physical examination, medical record review, and measurement of baseline levels of streptococcal antibodies. RESULTS: Significant group differences were found on several variables, such that children in whom PANDAS (versus without PANDAS) were more likely to have had dramatic onset, definite remissions, remission of neuropsychiatric symptoms during antibiotic therapy, a history of tonsillectomies/adenoidectomies, evidence of group A streptococcal infection, and clumsiness. CONCLUSION: The identification of clinical features associated with PANDAS should assist in delineating risks for this subtype of obsessive-compulsive disorder/tics.
OBJECTIVE: To explore associated clinical factors in children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS). STUDY DESIGN:Children with tics, obsessive-compulsive disorder, or both (n=109) were examined with personal and family history, diagnostic interview, physical examination, medical record review, and measurement of baseline levels of streptococcal antibodies. RESULTS: Significant group differences were found on several variables, such that children in whom PANDAS (versus without PANDAS) were more likely to have had dramatic onset, definite remissions, remission of neuropsychiatric symptoms during antibiotic therapy, a history of tonsillectomies/adenoidectomies, evidence of group A streptococcal infection, and clumsiness. CONCLUSION: The identification of clinical features associated with PANDAS should assist in delineating risks for this subtype of obsessive-compulsive disorder/tics.
Authors: Eric A Storch; Tanya K Murphy; Gary R Geffken; Ohel Soto; Muhammad Sajid; Pam Allen; Jonathan W Roberti; Erin M Killiany; Wayne K Goodman Journal: Psychiatry Res Date: 2004-11-30 Impact factor: 3.222
Authors: G Perugi; H S Akiskal; A Gemignani; C Pfanner; S Presta; A Milanfranchi; P Lensi; S Ravagli; I Maremmani; G B Cassano Journal: Eur Arch Psychiatry Clin Neurosci Date: 1998 Impact factor: 5.270
Authors: Jack L Paradise; Charles D Bluestone; D Kathleen Colborn; Beverly S Bernard; Howard E Rockette; Marcia Kurs-Lasky Journal: Pediatrics Date: 2002-07 Impact factor: 7.124
Authors: Tanya K Murphy; Muhammad Sajid; Ohel Soto; Nathan Shapira; Paula Edge; Mark Yang; Mark H Lewis; Wayne K Goodman Journal: Biol Psychiatry Date: 2004-01-01 Impact factor: 13.382
Authors: David Mataix-Cols; Bjarne Hansen; Manuel Mattheisen; Elinor K Karlsson; Anjené M Addington; Julia Boberg; Diana R Djurfeldt; Matthew Halvorsen; Paul Lichtenstein; Stian Solem; Kerstin Lindblad-Toh; Jan Haavik; Gerd Kvale; Christian Rück; James J Crowley Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2019-08-19 Impact factor: 3.568
Authors: Joshua M Nadeau; Cary Jordan; Robert R Selles; Monica S Wu; Morgan A King; Priyal D Patel; Camille E Hanks; Elysse B Arnold; Adam B Lewin; Tanya K Murphy; Eric A Storch Journal: J Child Adolesc Psychopharmacol Date: 2015-05 Impact factor: 2.576
Authors: Tanya K Murphy; Priyal D Patel; Joseph F McGuire; Allison Kennel; P Jane Mutch; E Carla Parker-Athill; Camille E Hanks; Adam B Lewin; Eric A Storch; Megan D Toufexis; Gul H Dadlani; Carina A Rodriguez Journal: J Child Adolesc Psychopharmacol Date: 2014-10-14 Impact factor: 2.576
Authors: Ekaterina A Khramtsova; Raphael Heldman; Eske M Derks; Dongmei Yu; Lea K Davis; Barbara E Stranger Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2018-11-20 Impact factor: 3.568
Authors: Thamotharampillai Dileepan; Erica D Smith; Daniel Knowland; Martin Hsu; Maryann Platt; Peter Bittner-Eddy; Brenda Cohen; Peter Southern; Elizabeth Latimer; Earl Harley; Dritan Agalliu; P Patrick Cleary Journal: J Clin Invest Date: 2015-12-14 Impact factor: 14.808